Table 2.
MLM predicting Depressive Symptoms as a function of change in smoking and alcohol use.
Parameter | B | 95% C.I. | S.E. | p |
---|---|---|---|---|
Mean Level (intercept) | ||||
Intercept | 0.36 | (−3.67 – 4.40) | 2.04 | .861 |
Baseline CES-D | 0.43 | (0.28 – 0.58) | .07 | <.001 |
Past MDD (vs. none) | 2.72 | (0.90 – 4.55) | .925 | .004 |
Male (vs. Female) | 0.73 | (−1.81 – 3.27) | 1.28 | .573 |
Baseline Cigarettes Per Week | 0.07 | (−.06 – 0.21) | .068 | .267 |
Baseline Drinks Per Week | −0.03 | (−0.09 – 0.03) | .029 | .335 |
Naltrexone (vs. Placebo) | 0.25 | (−2.17 – 2.67) | 1.22 | .837 |
Time-varying Smoking Status | ||||
50% or greater reduction (vs. | 4.02 | (1.70 – 6.33) | 1.17 | .001 |
< 50% reduction (vs. Abstinence) | 6.10 | (3.22 – 8.98) | 1.45 | <.001 |
Time-varying Alcohol Use | ||||
50% or greater reduction vs. | .41 | (−1.81 – 2.63) | 1.13 | .717 |
< 50% reduction or no change vs. | .25 | (−1.86 – 2.40) | 1.07 | .818 |
Variance Components | ||||
Level 1 | ||||
Within-person residuals | 32.53 | (25.87 – 40.90) | 3.79 | <.001 |
Level 2 | ||||
In mean level (intercept) | 22.57 | (11.75 – 43.34) | 7.51 | .003 |
In rate of change (time) | 2.90 | (1.22 – 7.06) | 1.31 | .026 |
In time-varying smoking abstinence | 8.53 | (2.11 – 34.41) | 6.006 | .160 |
In time-varying alcohol abstinence | 0.33 | (0.00 – 2.25) | 4.55 | .937 |
Note. CES-D = Center for Epidemiologic Studies Depression Scale; MDD = major depressive disorder